Transplant International (TRANSPL INT)
Transplant International is the official journal of the European Society for Organ Transplantation (ESOT) and the European Liver Transplant Association (ELTA). The aim of the journal is to serve as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies as well as editorials letters to the editor and occasionally reviews on the biology physiology and immunology of transplantation of tissues and organs are published. Both full-length articles and short papers are included in the journal. Publishing time for the latter is approximately six months provided major revisions are not needed. The journal is published in yearly volumes each volume containing six issues. Papers submitted to the journal are subject to peer review.
- Impact factor3.16Show impact factor historyHide impact factor history
- WebsiteTransplant International website
Other titlesTransplant international (Online)
Material typeDocument, Periodical, Internet resource
Document typeInternet Resource, Computer File, Journal / Magazine / Newspaper
- Author can archive a pre-print version
- Author cannot archive a post-print version
- Some journals impose embargoes typically of 6 or 12 months, occasionally of 24 months
- no listing of affected journals available as yet
- See Wiley-Blackwell entry for articles after February 2007
- Publisher version cannot be used
- On author or institutional or subject-based server
- Server must be non-commercial
- Publisher copyright and source must be acknowledged with set statement ("The definitive version is available at www.blackwell-synergy.com ")
- Articles in some journals can be made Open Access on payment of additional charge
- 'Blackwell Publishing' is an imprint of 'Wiley-Blackwell'
- Classification yellow
Publications in this journal
- [show abstract] [hide abstract]
ABSTRACT: Background: The sickest-first principle has been pursued with the introduction of the MELD-score as primary mode of allocation for donor livers. In Germany outcomes of liver transplantation may be negatively influenced by the transplantation of patients with very high MELD-scores and the use of donor organs with lower quality. Therefore some have claimed, allocation should be based more on outcome-oriented criteria. Methods: A survey with binary questions (yes/no) regarding the appreciation of values concerning the allocation of donor livers was performed among general medical outpatients of a university hospital. End-stage liver disease patients were excluded. 204 returned forms were analyzed. Percentages of valid answers are given. Results: Of 204 respondents, 47% were aged 50 yrs or younger, 46% were male. 88%, 73% and 41% of subjects answered, they would be willing to undergo transplantation for themselves with an estimated outcome of 20%, 50% and 80% one-year-mortality, respectively. Being asked, which of two case-examples should receive a donor organ, 68% of valid answers said the case with higher urgency and lower long-term survival should receive the organ, 60% said the case with better outcome but lower urgency. 70% said urgency was more important than long-term outcome as criteria for organ allocation. Under the assumption, urgency-based allocation would decrease results of liver transplantation, 58% refused to deny even the sickest patients transplantation. 78% said, patients likely to achieve 50% long-term survival should be transplanted. Conclusion: It appears that a majority of subjects prioritize urgency over efficiency per procedure. Representative surveys should be performed.Transplant International 11/2013; Vol 26(Suppl 1):3-27.
- [show abstract] [hide abstract]
ABSTRACT: The efficacy and safety of tacrolimus- and cyclosporine-based immunosuppressive regimens were compared in a prospectively defined subgroup of kidney transplant recipients from the European, open, multicentre, 2 : 1 randomised, parallel group study. Patients were stratified as high risk for immunological events if they had a panel-reactive antibodies grade greater than 80 % and/or a previous transplant functional for less than 1 year. The primary efficacy variables evaluated were the incidence of acute rejection, steroid usage and patient and graft survival. Safety was assessed based on adverse events and laboratory evaluations. At 1 year, the tacrolimus group (n = 22) had a lower incidence of biopsy-proven acute rejection (31.8 %) and a higher graft survival (86.0 %) than the 11 patients in the cyclosporine group (54.5 % and 72.0 %, respectively). The frequencies of adverse events were similar between the two groups. The tacrolimus regimen appears more beneficial for high risk patients than cyclosporine.Transplant International 08/2013; 11(1).
- Transplant International 06/2012;
- [show abstract] [hide abstract]
ABSTRACT: Although the persistence of donor-type hematopoietic cells in low numbers (microchimerism) is well established in some transplant recipients, its relevance for graft acceptance is still a matter of debate. On the other hand, clonal deletion of donor-specific alloreactive cells associated with mixed chimerism (macrochimerism) has reliably produced long-term graft tolerance in pre-clinical models. So far, the cytoablative conditioning regimens required to achieve mixed chimerism have hampered the clinical development of such protocols. Here, we discuss recent observations suggesting that the deliberate induction of hematopoietic cell chimerism might become a feasible strategy to achieve transplantation tolerance in clinics. Keywords Transplantation–Tolerance–Deletional–Non deletional–Immune-reconstitutionTransplant International 04/2012; 14(1):1-5.
- Transplant International 01/2012;
- Transplant International 01/2012; Accepted for publication.
- Transplant International 09/2011; 24:345.
- Transplant International 09/2011; 24:348.
- Transplant International 01/2011;
Article: Unintended consequence savingsTransplant International 01/2011; 24(S2):333.
- Transplant International 01/2010;
- Transplant International 01/2010; 23:12-12.
- Transplant International 07/2009; 22(6):599-600.
- Transplant International 06/2009; 22(5):531-3.
- Transplant International 05/2009; 22(4):385-6.
- Transplant International 05/2009; 22(4):494, author reply 495.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
Public Library of Science, Public...
ISSN: 1932-6203, Impact factor: 3.73
ISSN: 1879-1883, Impact factor: 2.36
Indian Society for Organ...
ISSN: 1873-2623, Impact factor: 0.95
Nature Publishing Group
ISSN: 1759-5053, Impact factor: 10.43
Nihon Kango Kagaku Gakkai, Blackwell...
ISSN: 1742-7924, Impact factor: 0.58
Italian Society of Nephrology
ISSN: 1724-6059, Impact factor: 2.02
ISSN: 1559-0283, Impact factor: 3.34